FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma

Personalized therapy for non-small cell lung cancer (NSCLC), particularly lung adenocarcinoma, has recently been significantly improved by the discovery of various molecular targets. However, this has not been the case for lung squamous cell carcinoma (SCC). In the present study, we identified the f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Int J Oncol
Autores principales: OKABE, NAOYUKI, EZAKI, JUNJI, YAMAURA, TAKUMI, MUTO, SATOSHI, OSUGI, JUN, TAMURA, HIROSUMI, IMAI, JUN-ICHI, ITO, EMI, YANAGISAWA, YUKA, HONMA, REIKO, GOTOH, MITSUKAZU, WATANABE, SHINYA, WAGURI, SATOSHI, SUZUKI, HIROYUKI
Formato: Artigo
Lenguaje:Inglês
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4324586/
https://ncbi.nlm.nih.gov/pubmed/25586059
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2015.2817
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares